Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5704
|
pubmed:dateCreated |
1979-6-26
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
E
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0028-0836
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
5
|
pubmed:volume |
278
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
494-5
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:431714-Canada,
pubmed-meshheading:431714-DNA, Recombinant,
pubmed-meshheading:431714-Economics,
pubmed-meshheading:431714-Federal Government,
pubmed-meshheading:431714-Government Regulation,
pubmed-meshheading:431714-Industry,
pubmed-meshheading:431714-Jurisprudence,
pubmed-meshheading:431714-Patents as Topic,
pubmed-meshheading:431714-United States
|
pubmed:year |
1979
|
pubmed:articleTitle |
Recombinant DNA research: private actions raise public eyebrows.
|
pubmed:publicationType |
News
|